Author

Jérôme Tamburini

University of GenevaORCID 0000-0002-0167-5996Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Sarah MoucheiD· 2 shared Alan Y. L. WongiD· 1 shared Almut S. EiseleiD· 1 shared Amy YuiD· 1 shared Arjun GargiD· 1 shared Boryana PetrovaiD· 1 shared Christian RécheriD· 1 shared Clément LarrueiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Sarah MoucheORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintOct 7, 2026

One-carbon metabolism sustains effector T cell function through cell-surface glycosylation

Peng Wang, Amy Yu, Mohammed Mutaher…·Naama Kanarek

This study shows folate deprivation impairs CD8+ T cell function by disrupting cell surface glycosylation, and increasing folate uptake enhances T cell anti-tumor activity.

DOI 10.64898/2026.10.06.756889

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyScience Translational MedicinePeer-reviewedJul 24, 2024

Ferritinophagy is a Druggable Vulnerability of Quiescent Leukemic Stem Cells

Clément Larrue, Sarah Mouche, Paolo Angelino…·Jérôme Tamburini

The paper identifies ferritinophagy as a therapeutic target in quiescent leukemic stem cells, showing that inhibiting NCOA4 reduces leukemia.

37 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky